Cargando…

Temporal changes in haematocrit following artemisinin-based combination treatments of uncomplicated falciparum malaria in children

BACKGROUND: Artemisinin-based combination treatments (ACTs) or intravenous artesunate are used in over 100 countries for uncomplicated or severe falciparum malaria. Although intravenous artesunate may cause delayed haemolytic anaemia, there is little evaluation of the temporal changes in haematocrit...

Descripción completa

Detalles Bibliográficos
Autores principales: Sowunmi, Akintunde, Akano, Kazeem, Ayede, Adejumoke I., Ntadom, Godwin, Fatunmbi, Bayo, Aderoyeje, Temitope, Adewoye, Elsie O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4620624/
https://www.ncbi.nlm.nih.gov/pubmed/26502714
http://dx.doi.org/10.1186/s12879-015-1219-y
_version_ 1782397328571760640
author Sowunmi, Akintunde
Akano, Kazeem
Ayede, Adejumoke I.
Ntadom, Godwin
Fatunmbi, Bayo
Aderoyeje, Temitope
Adewoye, Elsie O.
author_facet Sowunmi, Akintunde
Akano, Kazeem
Ayede, Adejumoke I.
Ntadom, Godwin
Fatunmbi, Bayo
Aderoyeje, Temitope
Adewoye, Elsie O.
author_sort Sowunmi, Akintunde
collection PubMed
description BACKGROUND: Artemisinin-based combination treatments (ACTs) or intravenous artesunate are used in over 100 countries for uncomplicated or severe falciparum malaria. Although intravenous artesunate may cause delayed haemolytic anaemia, there is little evaluation of the temporal changes in haematocrit following ACTs. METHODS: Clinical and parasitological parameters were measured before and following treatment of uncomplicated falciparum malaria in children with artesunate-amodiaquine (AA) or artemether-lumefantrine (AL) over 6-weeks. Changes in haematocrit were characterized in individual patients based on a haematocrit <30 % or ≥30 % before and following treatment. Kinetics of the deficit in haematocrit from <30 % until attainment of ≥30 % were estimated by a non-compartment model. RESULTS: In 248 of 1180 children eligible for evaluation, common temporal patterns were: no change or increase in haematocrit from ≥ 30 % [50 % of patients], haematocrit >30 % at presentation declining to <30 % within 2 weeks (early monophasic fall) [19 % of patients], and haematocrit <30 % at presentation increasing to ≥ 30 % [23 % of patients]. Haematocrit >30 % at presentation declining to <30 %, 3–5 weeks later (late monophasic fall) occurred in 7 children (3 %). Fall in haematocrit ≥5 units following treatment occurred in 57 children [23 %] between 14 and 28 days after treatment began. Baseline parasitaemia and proportion with > 100,000μL(-1 )asexual forms were significantly higher in children with ≥5 units compared to <5 units fall in haematocrit 21 or 28 days after treatment began. Irrespective of pattern, declines in haematocrit deficit from <30 % were mono-exponential, with similar half-times for AA- and AL-treated children (1.32 d versus 1.14 d). Anaemia half-time correlated significantly positively with anaemia recovery time in the same patients (r = 0.55, P < 0.0001). Bland-Altman analysis of 9 or 10 multiples of anaemia half-time and anaemia recovery times showed narrow limit of agreement with insignificant biases (P = 0.19 or 0.63, respectively). CONCLUSIONS: In uncomplicated falciparum malaria, increases or falls in haematocrit are common following ACTs. Falls in haematocrit ≥ 5 units are common and may or may not result in early or late anaemia. In children who recovered from acute falciparum malaria-associated anaemia following ACTs, decline in haematocrit deficit is mono-exponential. TRIALS REGISTRATION: Pan African Clinical Trial Registry PACTR201508001188143, 3 July 2015; PACTR201508001191898, 7 July 2015 http://www.pactr.org. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12879-015-1219-y) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4620624
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-46206242015-10-27 Temporal changes in haematocrit following artemisinin-based combination treatments of uncomplicated falciparum malaria in children Sowunmi, Akintunde Akano, Kazeem Ayede, Adejumoke I. Ntadom, Godwin Fatunmbi, Bayo Aderoyeje, Temitope Adewoye, Elsie O. BMC Infect Dis Research Article BACKGROUND: Artemisinin-based combination treatments (ACTs) or intravenous artesunate are used in over 100 countries for uncomplicated or severe falciparum malaria. Although intravenous artesunate may cause delayed haemolytic anaemia, there is little evaluation of the temporal changes in haematocrit following ACTs. METHODS: Clinical and parasitological parameters were measured before and following treatment of uncomplicated falciparum malaria in children with artesunate-amodiaquine (AA) or artemether-lumefantrine (AL) over 6-weeks. Changes in haematocrit were characterized in individual patients based on a haematocrit <30 % or ≥30 % before and following treatment. Kinetics of the deficit in haematocrit from <30 % until attainment of ≥30 % were estimated by a non-compartment model. RESULTS: In 248 of 1180 children eligible for evaluation, common temporal patterns were: no change or increase in haematocrit from ≥ 30 % [50 % of patients], haematocrit >30 % at presentation declining to <30 % within 2 weeks (early monophasic fall) [19 % of patients], and haematocrit <30 % at presentation increasing to ≥ 30 % [23 % of patients]. Haematocrit >30 % at presentation declining to <30 %, 3–5 weeks later (late monophasic fall) occurred in 7 children (3 %). Fall in haematocrit ≥5 units following treatment occurred in 57 children [23 %] between 14 and 28 days after treatment began. Baseline parasitaemia and proportion with > 100,000μL(-1 )asexual forms were significantly higher in children with ≥5 units compared to <5 units fall in haematocrit 21 or 28 days after treatment began. Irrespective of pattern, declines in haematocrit deficit from <30 % were mono-exponential, with similar half-times for AA- and AL-treated children (1.32 d versus 1.14 d). Anaemia half-time correlated significantly positively with anaemia recovery time in the same patients (r = 0.55, P < 0.0001). Bland-Altman analysis of 9 or 10 multiples of anaemia half-time and anaemia recovery times showed narrow limit of agreement with insignificant biases (P = 0.19 or 0.63, respectively). CONCLUSIONS: In uncomplicated falciparum malaria, increases or falls in haematocrit are common following ACTs. Falls in haematocrit ≥ 5 units are common and may or may not result in early or late anaemia. In children who recovered from acute falciparum malaria-associated anaemia following ACTs, decline in haematocrit deficit is mono-exponential. TRIALS REGISTRATION: Pan African Clinical Trial Registry PACTR201508001188143, 3 July 2015; PACTR201508001191898, 7 July 2015 http://www.pactr.org. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12879-015-1219-y) contains supplementary material, which is available to authorized users. BioMed Central 2015-10-26 /pmc/articles/PMC4620624/ /pubmed/26502714 http://dx.doi.org/10.1186/s12879-015-1219-y Text en © Sowunmi et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Sowunmi, Akintunde
Akano, Kazeem
Ayede, Adejumoke I.
Ntadom, Godwin
Fatunmbi, Bayo
Aderoyeje, Temitope
Adewoye, Elsie O.
Temporal changes in haematocrit following artemisinin-based combination treatments of uncomplicated falciparum malaria in children
title Temporal changes in haematocrit following artemisinin-based combination treatments of uncomplicated falciparum malaria in children
title_full Temporal changes in haematocrit following artemisinin-based combination treatments of uncomplicated falciparum malaria in children
title_fullStr Temporal changes in haematocrit following artemisinin-based combination treatments of uncomplicated falciparum malaria in children
title_full_unstemmed Temporal changes in haematocrit following artemisinin-based combination treatments of uncomplicated falciparum malaria in children
title_short Temporal changes in haematocrit following artemisinin-based combination treatments of uncomplicated falciparum malaria in children
title_sort temporal changes in haematocrit following artemisinin-based combination treatments of uncomplicated falciparum malaria in children
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4620624/
https://www.ncbi.nlm.nih.gov/pubmed/26502714
http://dx.doi.org/10.1186/s12879-015-1219-y
work_keys_str_mv AT sowunmiakintunde temporalchangesinhaematocritfollowingartemisininbasedcombinationtreatmentsofuncomplicatedfalciparummalariainchildren
AT akanokazeem temporalchangesinhaematocritfollowingartemisininbasedcombinationtreatmentsofuncomplicatedfalciparummalariainchildren
AT ayedeadejumokei temporalchangesinhaematocritfollowingartemisininbasedcombinationtreatmentsofuncomplicatedfalciparummalariainchildren
AT ntadomgodwin temporalchangesinhaematocritfollowingartemisininbasedcombinationtreatmentsofuncomplicatedfalciparummalariainchildren
AT fatunmbibayo temporalchangesinhaematocritfollowingartemisininbasedcombinationtreatmentsofuncomplicatedfalciparummalariainchildren
AT aderoyejetemitope temporalchangesinhaematocritfollowingartemisininbasedcombinationtreatmentsofuncomplicatedfalciparummalariainchildren
AT adewoyeelsieo temporalchangesinhaematocritfollowingartemisininbasedcombinationtreatmentsofuncomplicatedfalciparummalariainchildren